Unmasking of incipient amyotrophic lateral sclerosis by botulinum toxin therapy
Letter to the Editors
- 188 Downloads
KeywordsAmyotrophic Lateral Sclerosis Dystonia Botulinum Toxin Onyx Plantar Flexor
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Conflicts of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
The authors declare that they acted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki.
- 2.Winterholler M, Erbguth F (2001) Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach. JNNP 70:417–418Google Scholar
- 4.Erbguth F, Claus D, Engelhardt A, Dressler D (1993) Systemic effect of local botulinum toxin injections unmasks subclinical Lambert–Eaton myasthenic syndrome. JNNP 56(11):1235–1236Google Scholar
- 6.Gioltzoglou T, Cordivari C, Lees A (2005) Problems with botulinum toxin treatment in mitochondrial cytopathy: case report and review of the literature. JNNP 76:1594–1596Google Scholar
- 7.Girlanda P, Vita G, Messina C (1992) Botulinum toxin therapy: distant effects on neuromuscular transmission and autonomic nervous system. JNNP 55:844–845Google Scholar
© Springer-Verlag Berlin Heidelberg 2013